Vericel (VCEL) Inventory (2014 - 2026)
Vericel (VCEL) posted Inventory of $18.4 million for Q2 2026, little changed sequentially from $18.4 million in Q1 2026, and up 9.22% YoY from $16.8 million in Q2 2025.
Vericel (VCEL) Inventory (2014 - 2026) Analysis & Trends
Vericel has reported Inventory for 13 years, with the latest figure at $18.4 million in Q2 2026.
- Quarterly Inventory rose 9.22% year-over-year to $18.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $18.4 million (up 9.22% YoY) and the FY2025 annual result came in at $17.6 million, up 1.08% from the prior year.
- Inventory held at $18.4 million in Q2 2026 per VCEL's latest filing, from $18.4 million in the prior quarter.
- Over five years, Inventory peaked at $18.4 million in Q2 2026 and troughed at $12.6 million in Q3 2023.
- A 5-year average of $15.9 million and a median of $16.0 million in 2022 frame the typical range for Inventory.
- The sharpest annual moves came in 2022 and 2023: Inventory soared 39.36% in 2022, then retreated 24.56% in 2023.
- Over 5 years, Inventory stood at $16.0 million in 2022, then slipped by 18.13% to $13.1 million in 2023, then soared by 32.75% to $17.4 million in 2024, then grew by 1.08% to $17.6 million in 2025, then grew by 4.68% to $18.4 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $18.4 million, $18.4 million, and $17.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Vericel | 2.26 Bn | 2.10 Bn | 56.40 Mn | 18.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.38 Mn |
| Mar 31, 2026 | 18.35 Mn |
| Dec 31, 2025 | 17.56 Mn |
| Sep 30, 2025 | 18.16 Mn |
| Jun 30, 2025 | 16.83 Mn |
| Mar 31, 2025 | 17.11 Mn |
| Dec 31, 2024 | 17.37 Mn |
| Sep 30, 2024 | 15.76 Mn |
| Jun 30, 2024 | 14.89 Mn |
| Mar 31, 2024 | 13.56 Mn |
| Dec 31, 2023 | 13.09 Mn |
| Sep 30, 2023 | 12.62 Mn |
| Jun 30, 2023 | 13.88 Mn |
| Mar 31, 2023 | 15.37 Mn |
| Dec 31, 2022 | 15.99 Mn |
| Sep 30, 2022 | 16.73 Mn |
| Jun 30, 2022 | 15.93 Mn |
| Mar 31, 2022 | 14.39 Mn |
| Dec 31, 2021 | 13.38 Mn |
| Sep 30, 2021 | 13.06 Mn |